We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IFPMA Strengthens Ethics Code, Calls for Balanced Drug Ads
IFPMA Strengthens Ethics Code, Calls for Balanced Drug Ads
March 8, 2012
A new code of ethical business practice adopted by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) calls for strict adherence to global regulatory standards, balanced and accurate drug promotions and greater transparency in industry-sponsored clinical trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor